NCT07179549

Brief Summary

Hypoperfusion occurs following anaesthesia induction as a result of:

  1. 1.a reduction in venous return and cardiac output subsequent to the dilatation of the venous reservoir, and
  2. 2.a reduction in mean arterial pressure (MAP) secondary to arteriolar vasodilatation (reduction in arterial resistance) and decreased cardiac output. Many studies in the literature have focused on intraoperative hypotension and have reported an association between intensity x duration of hypotension and the occurrence of postoperative adverse events. Smaller interventional studies have suggested that improving stroke volume (SV, and therefore cardiac output) using fluid titration could reduce postoperative complications. Among postoperative adverse events consecutive to hypoperfusion, the occurrence of myocardial injury after noncardiac surgery (MINS) is well documented and is correlated to postoperative mortality at day 30.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
19mo left

Started Jan 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jan 2026Dec 2027

First Submitted

Initial submission to the registry

September 16, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 18, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

January 15, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

1.9 years

First QC Date

September 16, 2025

Last Update Submit

September 16, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Ultra-sensitive Troponin I plasma level

    Ultra-sensitive Troponin I plasma level variation following upper and lower GI endoscopy. Troponin I will be measured immediately prior to anaesthesia induction (IV line placement) and before patient discharge of the hospital, i.e.: 4 (±1) hours after the procedure.

    4 hours

  • Ultra-sensitive Troponin I plasma level variation following upper and lower GI endoscopy.

    Ultra-sensitive Troponin I plasma level variation following upper and lower GI endoscopy. Troponin I will be measured immediately prior to anaesthesia induction (IV line placement) and before patient discharge from the hospital, i.e.: 4 (±1) hours after the procedure

    4 hours

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients considered high risk

You may qualify if:

  • Outpatients scheduled for upper and lower GI endoscopy
  • ASA class 3 or 4: patients considered by anesthesiologists at "high risk" of postoperative complications, based on their comorbidities

You may not qualify if:

  • Patients with renal failure, with glomerular filtration rate\<40 ml/min
  • Patient not covered by social security
  • Patient is pregnant
  • Protected Patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Bernard Professor. Cholley, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2025

First Posted

September 18, 2025

Study Start

January 15, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

September 18, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

privacy, ethical, or regulatory reasons